+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07028749

Phase 2b Randomized Study of MAR001 Compared to Placebo in Adults With Elevated Triglycerides and Remnant Cholesterol TYDAL-TIMI 78

Led by Marea Therapeutics · Updated on 2026-09-02

316

Participants Needed

55

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of MAR001 compared to a placebo in adults with elevated triglycerides TG and remnant cholesterol RC. This Phase 2b, randomized, double-blind, placebo-controlled study aims to understand how MAR001 impacts TG levels in people with specific cholesterol conditions. The study includes two parts, focusing on different ranges of baseline triglyceride levels to assess the treatments effects. Participants in Part A with TG levels between 150 and 880 mgdL will receive one of three doses of MAR001 or placebo by subcutaneous injection every four weeks. In Part B, participants with higher TG levels between 450 and 2000 mgdL will receive a dose chosen based on Part A results, also by subcutaneous injection every four weeks. The study consists of a screening period lasting up to 8 weeks, a 24-week treatment phase, and a 12-week safety follow-up with two clinic visits. During the trial, participants will undergo assessments including clinical visits at specified weeks, laboratory tests, and monitoring for safety and treatment effects. Researchers will measure changes in triglyceride levels primarily at 12 weeks, along with secondary outcomes at various time points. The total participation duration includes screening, treatment, and follow-up periods, allowing for comprehensive evaluation of MAR001s impact and safety in this population.

CONDITIONS

Brief Title

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Research Team

M

Matty Hughes

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here